Clinical Trials Browser

Interventional × Neoplastic Cells, Circulating × 90 days × Clear all

Breast Neoplasms, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03776591 2026-05-14

D3/CME

Phase NA Active not recruiting

128 enrolled

Gastrointestinal

Colonic Neoplasms, Lymphatic Metastasis, Neoplastic Cells, Circulating

NCT04771871 2026-05-07

TARMAC

Phase 2 Recruiting

42 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Triple Negative Breast Neoplasms

NCT02072616 2026-05-04

CTC-Pancreas

Phase NA Terminated

101 enrolled

Neoplastic Cells, Circulating

NCT06807502 2026-04-24

PROBE-CTC

Phase NA Recruiting

93 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis

NCT05247164 2026-04-15

EUPhORIC

Phase NA Completed

23 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06067503 2026-04-13

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT03960021 2026-03-27

ARFIM

Phase NA Terminated

20 enrolled 2 charts

Gastrointestinal

Colonic Neoplasms, Neoplastic Cells, Circulating, Neoplasms

Clinical Trials

CAPT CTC

D3/CME

TARMAC

CTC-Pancreas

PROBE-CTC

EUPhORIC

Biomarkers to Detect Endocrine Therapy Resistance

ARFIM